APO Research
Talk to an analyst

APO RESEARCH · REPORT

Remdesivir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Remdesivir Industry Growth and Trends Forecast to 2032

2 January 202690 pages

Choose your research edition.

Industry ResearchRemdesivir Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Remdesivir Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Remdesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Remdesivir Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Remdesivir Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Remdesivir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Remdesivir include Kelun Pharma, Hunan Warrant Pharmaceutical, Hainan Haiyao, Bright Gene and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Remdesivir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Remdesivir market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Remdesivir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Remdesivir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Remdesivir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Remdesivir Market by Company

Kelun Pharma

Hunan Warrant Pharmaceutical

Hainan Haiyao

Bright Gene

Gilead Sciences

Remdesivir Segment by Type

10 mM*1 mL in DMSO

100mg

10mg

50mg

5mg

Remdesivir Segment by Application

Drug Store

Hospital

Clinics

Others

Remdesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remdesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Remdesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remdesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Remdesivir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Remdesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10 mM*1 mL in DMSO Table 2. Major Company of 100mg Table 3. Major Company of 10mg Table 4. Major Company of 50mg Table 5. Major Company of 5mg Table 6. Global Remdesivir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Remdesivir Sales by Type (2021-2026) & (K Units) Table 8. Global Remdesivir Sales Market Share in Volume by Type (2021-2026) Table 9. Global Remdesivir Sales by Type (2021-2026) & (US$ Million) Table 10. Global Remdesivir Sales Market Share in Value by Type (2021-2026) Table 11. Global Remdesivir Price by Type (2021-2026) & (US$/Unit) Table 12. Global Remdesivir Sales by Type (2027-2032) & (K Units) Table 13. Global Remdesivir Sales Market Share in Volume by Type (2027-2032) Table 14. Global Remdesivir Sales by Type (2027-2032) & (US$ Million) Table 15. Global Remdesivir Sales Market Share in Value by Type (2027-2032) Table 16. Global Remdesivir Price by Type (2027-2032) & (US$/Unit) Table 17. North America Remdesivir Sales by Type (2021-2026) & (K Units) Table 18. North America Remdesivir Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Remdesivir Sales by Type (2021-2026) & (K Units) Table 20. Europe Remdesivir Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Remdesivir Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Remdesivir Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Remdesivir Sales by Type (2021-2026) & (K Units) Table 24. Latin America Remdesivir Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Remdesivir Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Remdesivir Sales by Type (2021-2026) & (US$ Million) Table 27. Remdesivir Industry Trends Table 28. Remdesivir Industry Drivers Table 29. Remdesivir Industry Opportunities and Challenges Table 30. Remdesivir Industry Restraints Table 31. Global Remdesivir Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Remdesivir Revenue Market Share by Company (2021-2026) Table 33. Global Remdesivir Sales by Company (2021-2026) & (K Units) Table 34. Global Remdesivir Sales Share by Company (2021-2026) Table 35. Global Remdesivir Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Remdesivir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Remdesivir Major Company Production Sites and Headquarters Table 38. Global Remdesivir Company, Product Type & Application Table 39. Global Remdesivir Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Remdesivir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Remdesivir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Remdesivir Sales by Region (2021-2026) & (K Units) Table 44. Global Remdesivir Sales Market Share in Volume by Region (2021-2026) Table 45. Global Remdesivir Sales by Region (2021-2026) & (US$ Million) Table 46. Global Remdesivir Sales Market Share in Value by Region (2021-2026) Table 47. Global Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Remdesivir Sales by Region (2027-2032) & (K Units) Table 49. Global Remdesivir Sales Market Share in Volume by Region (2027-2032) Table 50. Global Remdesivir Sales by Region (2027-2032) & (US$ Million) Table 51. Global Remdesivir Sales Market Share in Value by Region (2027-2032) Table 52. Global Remdesivir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Remdesivir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Remdesivir Sales by Application (2021-2026) & (K Units) Table 55. Global Remdesivir Sales Market Share in Volume by Application (2021-2026) Table 56. Global Remdesivir Sales by Application (2021-2026) & (US$ Million) Table 57. Global Remdesivir Sales Market Share in Value by Application (2021-2026) Table 58. Global Remdesivir Price by Application (2021-2026) & (US$/Unit) Table 59. Global Remdesivir Sales by Application (2027-2032) & (K Units) Table 60. Global Remdesivir Sales Market Share in Volume by Application (2027-2032) Table 61. Global Remdesivir Sales by Application (2027-2032) & (US$ Million) Table 62. Global Remdesivir Sales Market Share in Value by Application (2027-2032) Table 63. Global Remdesivir Price by Application (2027-2032) & (US$/Unit) Table 64. North America Remdesivir Sales by Application (2021-2026) & (K Units) Table 65. North America Remdesivir Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Remdesivir Sales by Application (2021-2026) & (K Units) Table 67. Europe Remdesivir Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Remdesivir Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Remdesivir Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Remdesivir Sales by Application (2021-2026) & (K Units) Table 71. Latin America Remdesivir Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Remdesivir Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Remdesivir Sales by Application (2021-2026) & (US$ Million) Table 74. Kelun Pharma Company Information Table 75. Kelun Pharma Business Overview Table 76. Kelun Pharma Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Kelun Pharma Remdesivir Product Portfolio Table 78. Kelun Pharma Recent Development Table 79. Hunan Warrant Pharmaceutical Company Information Table 80. Hunan Warrant Pharmaceutical Business Overview Table 81. Hunan Warrant Pharmaceutical Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hunan Warrant Pharmaceutical Remdesivir Product Portfolio Table 83. Hunan Warrant Pharmaceutical Recent Development Table 84. Hainan Haiyao Company Information Table 85. Hainan Haiyao Business Overview Table 86. Hainan Haiyao Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hainan Haiyao Remdesivir Product Portfolio Table 88. Hainan Haiyao Recent Development Table 89. Bright Gene Company Information Table 90. Bright Gene Business Overview Table 91. Bright Gene Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bright Gene Remdesivir Product Portfolio Table 93. Bright Gene Recent Development Table 94. Gilead Sciences Company Information Table 95. Gilead Sciences Business Overview Table 96. Gilead Sciences Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Gilead Sciences Remdesivir Product Portfolio Table 98. Gilead Sciences Recent Development Table 99. North America Remdesivir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. North America Remdesivir Sales by Country (2021-2026) & (K Units) Table 101. North America Remdesivir Sales Market Share by Country (2021-2026) Table 102. North America Remdesivir Sales Forecast by Country (2027-2032) & (K Units) Table 103. North America Remdesivir Sales Market Share Forecast by Country (2027-2032) Table 104. North America Remdesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Remdesivir Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Remdesivir Market Share by Country (2021-2026) Table 107. North America Remdesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Remdesivir Market Share Forecast by Country (2027-2032) Table 109. Europe Remdesivir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Europe Remdesivir Sales by Country (2021-2026) & (K Units) Table 111. Europe Remdesivir Sales Market Share by Country (2021-2026) Table 112. Europe Remdesivir Sales Forecast by Country (2027-2032) & (K Units) Table 113. Europe Remdesivir Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Remdesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Remdesivir Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Remdesivir Market Share by Country (2021-2026) Table 117. Europe Remdesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Remdesivir Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Remdesivir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Remdesivir Sales by Country (2021-2026) & (K Units) Table 121. Asia-Pacific Remdesivir Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Remdesivir Sales Forecast by Country (2027-2032) & (K Units) Table 123. Asia-Pacific Remdesivir Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Remdesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Remdesivir Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Remdesivir Market Share by Country (2021-2026) Table 127. Asia-Pacific Remdesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Remdesivir Market Share Forecast by Country (2027-2032) Table 129. Latin America Remdesivir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Latin America Remdesivir Sales by Country (2021-2026) & (K Units) Table 131. Latin America Remdesivir Sales Market Share by Country (2021-2026) Table 132. Latin America Remdesivir Sales Forecast by Country (2027-2032) & (K Units) Table 133. Latin America Remdesivir Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Remdesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Remdesivir Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Remdesivir Market Share by Country (2021-2026) Table 137. Latin America Remdesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Remdesivir Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Remdesivir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Remdesivir Sales by Country (2021-2026) & (K Units) Table 141. Middle East and Africa Remdesivir Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Remdesivir Sales Forecast by Country (2027-2032) & (K Units) Table 143. Middle East and Africa Remdesivir Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Remdesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Remdesivir Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Remdesivir Market Share by Country (2021-2026) Table 147. Middle East and Africa Remdesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Remdesivir Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Remdesivir Distributors List Table 152. Remdesivir Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Remdesivir Image Figure 2. Global Remdesivir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Remdesivir Market Size (2021-2032) & (US$ Million) Figure 4. Global Remdesivir Sales (2021-2032) & (K Units) Figure 5. 10 mM*1 mL in DMSO Image Figure 6. Global 10 mM*1 mL in DMSO Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100mg Image Figure 8. Global 100mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 10mg Image Figure 10. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 50mg Image Figure 12. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. 5mg Image Figure 14. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Remdesivir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Remdesivir Market Share by Type 2025 VS 2032 Figure 17. North America Remdesivir Sales Market Share in Volume by Type in 2025 Figure 18. North America Remdesivir Sales Market Share in Value by Type in 2025 Figure 19. Europe Remdesivir Sales Market Share in Volume by Type in 2025 Figure 20. Europe Remdesivir Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Remdesivir Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Remdesivir Sales Market Share in Value by Type in 2025 Figure 23. Latin America Remdesivir Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Remdesivir Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Remdesivir Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Remdesivir Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Remdesivir Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Drug Store Image Figure 30. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Clinics Image Figure 34. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Remdesivir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Remdesivir Market Share by Application 2025 VS 2032 Figure 39. North America Remdesivir Sales Market Share in Volume by Application in 2025 Figure 40. North America Remdesivir Sales Market Share in Value by Application in 2025 Figure 41. Europe Remdesivir Sales Market Share in Volume by Application in 2025 Figure 42. Europe Remdesivir Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Remdesivir Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Remdesivir Sales Market Share in Value by Application in 2025 Figure 45. Latin America Remdesivir Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Remdesivir Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Remdesivir Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Remdesivir Sales Market Share in Value by Application in 2025 Figure 49. North America Remdesivir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Remdesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Remdesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Remdesivir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Remdesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Remdesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Remdesivir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Remdesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Remdesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Remdesivir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Remdesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Remdesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Remdesivir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Remdesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Remdesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Remdesivir Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Remdesivir Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 10 mM*1 mL in DMSO
  • 100mg
  • 10mg
  • 50mg
  • 5mg
Applications
  • Drug Store
  • Hospital
  • Clinics
  • Others
Companies covered
  • Kelun Pharma
  • Hunan Warrant Pharmaceutical
  • Hainan Haiyao
  • Bright Gene
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Remdesivir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Remdesivir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Remdesivir Market by Type
  6. 1.3.1 10 mM*1 mL in DMSO
  7. 1.3.2 100mg
  8. 1.3.3 10mg
  9. 1.3.4 50mg
  10. 1.3.5 5mg
  11. 1.4 Global Remdesivir Market Size by Type
  12. 1.4.1 Global Remdesivir Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Remdesivir Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Remdesivir Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Remdesivir Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Remdesivir Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Remdesivir Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Remdesivir Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Remdesivir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Remdesivir Industry Trends
  2. 2.2 Remdesivir Industry Drivers
  3. 2.3 Remdesivir Industry Opportunities and Challenges
  4. 2.4 Remdesivir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Remdesivir Revenue (2021-2026)
  2. 3.2 Global Top Players by Remdesivir Sales (2021-2026)
  3. 3.3 Global Top Players by Remdesivir Price (2021-2026)
  4. 3.4 Global Remdesivir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Remdesivir Major Company Production Sites & Headquarters
  6. 3.6 Global Remdesivir Company, Product Type & Application
  7. 3.7 Global Remdesivir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Remdesivir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Remdesivir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Remdesivir Tier 1, Tier 2, and Tier 3
4 Remdesivir Regional Status and Outlook
  1. 4.1 Global Remdesivir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Remdesivir Historic Market Size by Region
  3. 4.2.1 Global Remdesivir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Remdesivir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Remdesivir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Remdesivir Forecasted Market Size by Region
  7. 4.3.1 Global Remdesivir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Remdesivir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Remdesivir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Remdesivir by Application
  1. 5.1 Remdesivir Market by Application
  2. 5.1.1 Drug Store
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Remdesivir Market Size by Application
  7. 5.2.1 Global Remdesivir Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Remdesivir Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Remdesivir Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Remdesivir Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Remdesivir Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Remdesivir Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Remdesivir Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Remdesivir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Kelun Pharma
  2. 6.1.1 Kelun Pharma Company Information
  3. 6.1.2 Kelun Pharma Business Overview
  4. 6.1.3 Kelun Pharma Remdesivir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Kelun Pharma Remdesivir Product Portfolio
  6. 6.1.5 Kelun Pharma Recent Developments
  7. 6.2 Hunan Warrant Pharmaceutical
  8. 6.2.1 Hunan Warrant Pharmaceutical Company Information
  9. 6.2.2 Hunan Warrant Pharmaceutical Business Overview
  10. 6.2.3 Hunan Warrant Pharmaceutical Remdesivir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hunan Warrant Pharmaceutical Remdesivir Product Portfolio
  12. 6.2.5 Hunan Warrant Pharmaceutical Recent Developments
  13. 6.3 Hainan Haiyao
  14. 6.3.1 Hainan Haiyao Company Information
  15. 6.3.2 Hainan Haiyao Business Overview
  16. 6.3.3 Hainan Haiyao Remdesivir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hainan Haiyao Remdesivir Product Portfolio
  18. 6.3.5 Hainan Haiyao Recent Developments
  19. 6.4 Bright Gene
  20. 6.4.1 Bright Gene Company Information
  21. 6.4.2 Bright Gene Business Overview
  22. 6.4.3 Bright Gene Remdesivir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bright Gene Remdesivir Product Portfolio
  24. 6.4.5 Bright Gene Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Remdesivir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gilead Sciences Remdesivir Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
7 North America by Country
  1. 7.1 North America Remdesivir Sales by Country
  2. 7.1.1 North America Remdesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Remdesivir Sales by Country (2021-2026)
  4. 7.1.3 North America Remdesivir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Remdesivir Market Size by Country
  6. 7.2.1 North America Remdesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Remdesivir Market Size by Country (2021-2026)
  8. 7.2.3 North America Remdesivir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Remdesivir Sales by Country
  2. 8.1.1 Europe Remdesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Remdesivir Sales by Country (2021-2026)
  4. 8.1.3 Europe Remdesivir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Remdesivir Market Size by Country
  6. 8.2.1 Europe Remdesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Remdesivir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Remdesivir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Remdesivir Sales by Country
  2. 9.1.1 Asia-Pacific Remdesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Remdesivir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Remdesivir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Remdesivir Market Size by Country
  6. 9.2.1 Asia-Pacific Remdesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Remdesivir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Remdesivir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Remdesivir Sales by Country
  2. 10.1.1 South America Remdesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Remdesivir Sales by Country (2021-2026)
  4. 10.1.3 South America Remdesivir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Remdesivir Market Size by Country
  6. 10.2.1 South America Remdesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Remdesivir Market Size by Country (2021-2026)
  8. 10.2.3 South America Remdesivir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Remdesivir Sales by Country
  2. 11.1.1 Middle East and Africa Remdesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Remdesivir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Remdesivir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Remdesivir Market Size by Country
  6. 11.2.1 Middle East and Africa Remdesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Remdesivir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Remdesivir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Remdesivir Value Chain Analysis
  2. 12.1.1 Remdesivir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Remdesivir Production Mode & Process
  7. 12.2 Remdesivir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Remdesivir Distributors
  10. 12.2.3 Remdesivir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst